AMRN - Amarin Corp PLC Stock Price, Fair Value and News

0.87USD+0.01 (+1.16%)Market Closed

Market Summary

USD0.87+0.01

Market Closed

1.16%

AMRN Stock Price

View Fullscreen

AMRN RSI Chart

AMRN Valuation

Market Cap

355.7M

Price/Earnings (Trailing)

-6.02

Price/Sales (Trailing)

1.16

EV/EBITDA

-2.92

Price/Free Cashflow

51.7

AMRN Price/Sales (Trailing)

AMRN Profitability

EBT Margin

-17.49%

Return on Equity

-10.71%

Return on Assets

-7.11%

Free Cashflow Yield

1.93%

AMRN Fundamentals

AMRN Revenue

Revenue (TTM)

306.9M

Rev. Growth (Yr)

-17.21%

Rev. Growth (Qtr)

13.11%

AMRN Earnings

Earnings (TTM)

-59.1M

Earnings Growth (Yr)

-775.35%

Earnings Growth (Qtr)

70.06%

Breaking Down AMRN Revenue

Last 7 days

1.2%

Last 30 days

-2.2%

Last 90 days

-34.1%

How does AMRN drawdown profile look like?

AMRN Financial Health

Current Ratio

2.8

Debt/Equity

0.02

Debt/Cashflow

0.77

AMRN Investor Care

Shares Dilution (1Y)

1.11%

Diluted EPS (TTM)

-0.15

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2023	360.5M	346.3M	322.4M	306.9M
2022	535.6M	475.6M	423.4M	369.2M
2021	601.2M	620.4M	605.9M	583.2M
2020	511.5M	546.0M	590.1M	614.1M
2019	258.6M	306.7M	363.8M	429.8M
2018	190.4M	197.8M	205.8M	229.2M
2017	139.2M	151.3M	165.9M	181.1M
2016	91.4M	106.8M	118.0M	130.1M
2015	59.2M	64.3M	71.6M	81.8M
2014	35.0M	42.1M	47.8M	54.2M
2013	0	0	0	26.4M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Amarin Corp PLC

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Jan 31, 2024	berg aaron	acquired	-	-	79,500	evp, president us
Jan 31, 2024	reilly thomas charles	sold (taxes)	-30,444	1.24	-24,552	evp and cfo
Jan 31, 2024	berg aaron	sold (taxes)	-50,619	1.24	-40,822	evp, president us
Jan 31, 2024	ketchum steven b	sold (taxes)	-51,071	1.24	-41,187	chief scientific officer
Jan 31, 2024	reilly thomas charles	acquired	-	-	44,933	evp and cfo
Jan 31, 2024	ketchum steven b	acquired	-	-	79,500	chief scientific officer
Jan 22, 2024	holt patrick	bought	15,724	1.09	14,426	president and ceo
Jan 10, 2024	berg aaron	acquired	-	-	51,500	evp, president us
Jan 10, 2024	berg aaron	sold (taxes)	-27,367	0.97	-28,214	evp, president us
Jan 10, 2024	reilly thomas charles	acquired	-	-	51,500	evp and cfo

Which funds bought or sold AMRN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 25, 2024	Regis Management CO LLC	unchanged	-	7,000	312,000	0.10%
Apr 25, 2024	Checchi Capital Advisers, LLC	unchanged	-	2,179	93,342	0.01%
Apr 25, 2024	Allworth Financial LP	unchanged	-	3.00	90.00	-%
Apr 25, 2024	Lindbrook Capital, LLC	unchanged	-	4.00	178	-%
Apr 25, 2024	SIMPLEX TRADING, LLC	reduced	-97.91	-24,000	-	-%
Apr 24, 2024	Newbridge Financial Services Group, Inc.	new	-	37,325	37,325	0.02%
Apr 24, 2024	Simplicity Wealth,LLC	new	-	417,650	417,650	0.01%
Apr 24, 2024	Spire Wealth Management	added	0.08	-398	2,227	-%
Apr 24, 2024	Cambridge Investment Research Advisors, Inc.	added	7.95	2,000	19,000	-%
Apr 24, 2024	Dakota Wealth Management	new	-	19,986	19,986	-%

Are Funds Buying or Selling AMRN?

Are funds buying AMRN calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own AMRN

No. of Funds

Unveiling Amarin Corp PLC's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Dec 08, 2023	morgan stanley	1.6%	6,427,739	SC 13G/A
Dec 05, 2023	sarissa capital management lp	8.20%	33,470,000	SC 13D/A
Feb 10, 2023	sarissa capital management lp	-	0	SC 13D/A
Dec 12, 2022	baker bros. advisors lp	0.0%	0	SC 13G/A
Oct 11, 2022	sarissa capital management lp	5.95%	2.4e+07	SC 13D/A
Feb 14, 2020	baker bros. advisors lp	9.6%	34,496,685	SC 13G/A

Recent SEC filings of Amarin Corp PLC

View All Filings

Date Filed	Form Type	Document
Apr 22, 2024	8-K	Current Report
Apr 19, 2024	4	Insider Trading
Apr 19, 2024	4	Insider Trading
Apr 19, 2024	4	Insider Trading
Apr 19, 2024	4	Insider Trading
Apr 19, 2024	4	Insider Trading
Apr 19, 2024	4	Insider Trading
Apr 19, 2024	4	Insider Trading
Apr 19, 2024	4	Insider Trading
Apr 03, 2024	8-K	Current Report

Peers (Alternatives to Amarin Corp PLC)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
JNJ	352.0B	85.2B	-7.49%	-10.35%	10.01	4.13	6.46%	95.94%
MRK	332.3B	60.1B	-0.42%	13.93%	910.36	5.53	1.40%	-97.49%
AMGN	144.7B	28.2B	-5.70%	12.33%	21.54	5.13	7.09%	2.52%
PFE	143.3B	46.5B	-8.64%	-34.49%	-103.22	3.08	42.59%	-114.62%
GILD	81.5B	27.1B	-10.34%	-21.65%	14.4	3.01	-0.60%	23.36%
TEVA	15.4B	15.8B	-4.37%	61.97%	-26.83	0.97	6.17%	76.47%
MID-CAP
PRGO	4.3B	4.7B	1.49%	-12.83%	-340.71	0.93	4.58%	90.97%
ALKS	4.1B	1.7B	-9.36%	-12.84%	11.6	2.48	49.61%	324.78%
BHC	3.2B	8.8B	-16.97%	22.33%	-5.38	0.36	7.79%	-163.11%
AMPH	2.0B	644.4M	-5.51%	13.03%	14.38	3.07	29.14%	50.51%
SMALL-CAP
TLRY	1.4B	743.2M	-28.23%	-25.52%	-3.91	1.85	24.65%	80.36%
TXMD	21.5M	1.3M	-17.33%	-48.76%	-2.09	16.47	-98.14%	-109.18%
ACRX	17.8M	-	-4.55%	55.56%	-0.97	0.22	2882.68%	-138.52%
AGRX	2.7M	19.6M	8.11%	-93.94%	-0.19	0.14	80.00%	43.08%
ACOR	931.6K	117.6M	-96.48%	-95.45%	0	0.01	-0.79%	-283.60%

Amarin Corp PLC News

Latest updates

Amarin Corp PLC Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	13.1%	74,713,000	66,056,000	80,167,000	85,975,000	90,245,000	89,878,000	94,440,000	94,630,000	144,491,000	142,038,000	154,488,000	142,170,000	167,251,000	156,499,000	135,317,000	154,993,000	143,277,000	112,408,000	100,792,000	73,278,000	77,330,000
Gross Profit	51.3%	45,124,000	29,822,000	42,668,000	47,927,000	63,604,000	62,859,000	43,630,000	72,391,000	113,856,000	111,827,000	122,333,000	113,844,000	132,482,500	123,428,000	106,520,000	120,186,000	112,612,000	86,964,000	78,022,000	56,138,000	59,821,000
Operating Expenses	-2.6%	49,961,000	51,273,000	66,627,000	65,268,000	73,190,000	68,003,000	106,462,000	100,698,000	97,723,000	124,900,000	113,560,000	115,175,000	125,324,500	130,368,000	102,364,000	144,215,000	107,122,000	91,482,000	80,536,000	78,875,000	91,592,500
S&GA Expenses	-3.3%	43,941,000	45,457,000	50,953,000	59,587,000	68,131,000	58,745,000	86,893,000	90,647,000	92,368,000	102,965,000	107,203,000	105,798,000	116,816,000	120,164,000	92,395,000	133,937,000	96,025,000	82,559,000	73,406,000	71,633,000	79,685,500
R&D Expenses	13.4%	5,791,000	5,105,000	5,642,000	5,681,000	5,239,000	5,765,000	9,356,000	10,051,000	5,753,000	7,820,000	6,357,000	9,377,000	8,508,500	10,204,000	9,969,000	10,278,000	11,097,000	8,923,000	7,130,000	7,242,000	11,907,000
EBITDA Margin	-Infinity%	-0.17	-	-0.12	-0.25	-0.28	-0.19	-0.19	-0.03	0.02	0.01	0.02	0.01	-0.02	-0.02	-0.04	-0.04	-0.04	-0.18	-0.23	-0.41	-0.47
Interest Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	723,000	689,000	318,000	875,000	3,049,000	-11,405,000	7,273,000	7,709,000	-7,158,000
Income Taxes	565.1%	3,332,000	501,000	-355,000	1,964,000	-7,629,000	1,257,000	5,157,000	3,213,000	1,695,000	184,000	1,059,000	624,000	2,674,000	430,000	-	-2,359,000	77,000	16,000	-	-	-729,000
Earnings Before Taxes	87.0%	-2,449,000	-18,810,000	-17,915,000	-14,496,000	-6,773,000	-3,883,000	-64,799,000	-28,350,000	16,393,000	-12,967,000	8,867,000	-1,002,000	7,600,000	-6,358,000	4,415,000	-22,912,000	7,232,000	-3,462,000	-1,820,000	-24,431,000	-33,573,000
EBT Margin	2.8%	-0.17	-0.18	-0.12	-0.25	-0.28	-0.19	-0.19	-0.03	0.02	0.00	0.01	0.01	-0.03	-0.03	-0.03	-0.04	-0.05	-0.17	-0.27	-0.45	-0.51
Net Income	70.1%	-5,781,000	-19,311,000	-17,560,000	-16,460,000	856,000	-5,140,000	-69,956,000	-31,563,000	14,698,000	-13,151,000	7,808,000	-1,626,000	4,926,000	-6,788,000	4,415,000	-20,553,000	7,068,000	-3,462,000	-1,820,000	-24,431,000	-33,670,000
Net Income Margin	-18.3%	-0.19	-0.16	-0.11	-0.25	-0.29	-0.22	-0.21	-0.04	0.01	0.00	0.01	0.00	-0.03	-0.03	-0.02	-0.04	-0.05	-0.17	-0.28	-0.45	-0.51
Free Cashflow	-108.8%	-645,000	7,329,000	7,204,000	-7,008,000	1,552,000	-18,213,000	-64,584,000	-98,847,000	-28,240,000	-4,540,000	-15,053,000	-18,704,000	-38,323,000	10,852,000	1,587,000	3,886,000	-9,300,000	20,437,000	15,904,000	-38,094,000	-32,308,000

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Assets	-0.9%	832	839	860	860	886	908	973	974	1,068	1,036	1,045	990	966	960	915	926	882	867	390	372	386
Current Assets	1.0%	725	718	706	684	689	687	719	773	879	963	996	931	879	889	828	817	855	848	372	355	378
Cash Equivalents	-26.4%	199	271	233	191	218	241	228	219	219	223	327	291	187	207	214	329	645	673	222	211	249
Inventory	1.6%	259	255	227	226	229	228	226	268	235	309	272	231	189	149	125	92.00	77.00	55.00	46.00	58.00	58.00
Net PPE	-22.4%	0.00	0.00	0.00	0.00	1.00	1.00	1.00	1.00	1.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	2.00	1.00	0.00	0.00
Liabilities	-2.2%	280	286	291	275	291	320	393	333	401	393	400	356	339	353	312	340	274	271	241	231	233
Current Liabilities	-2.8%	259	267	271	244	259	287	362	301	371	365	370	326	307	326	283	310	242	230	185	162	157
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9.00	23.00	35.00	46.00
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	10.00	22.00	37.00	50.00	51.00	45.00	39.00	34.00
LT Debt, Non Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9.00	23.00	35.00	46.00
Shareholder's Equity	-0.2%	552	553	569	585	595	588	580	641	667	642	645	635	628	607	603	586	608	596	149	141	152
Retained Earnings	-0.4%	-1,586	-1,580	-1,561	-1,543	-1,527	-1,528	-1,522	-1,453	-1,421	-1,436	-1,422	-1,430	-1,429	-1,434	-1,427	-1,431	-1,411	-1,418	-1,414	-1,412	-1,388
Additional Paid-In Capital	0.2%	1,899	1,895	1,892	1,890	1,885	1,879	1,870	1,861	1,855	1,845	1,835	1,831	1,818	1,799	1,787	1,775	1,764	1,746	1,312	1,301	1,283
Shares Outstanding	0.1%	409	409	408	407	404	400	398	398	396	397	396	395	382	379	373	361	343	351	331	329	297
Float	-	-	-	485	-	-	-	721	-	-	-	1,710	-	-	-	2,645	-	-	-	6,372	-	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Cashflow From Operations	-108.8%	-645	7,329	7,204	-7,008	1,552	-18,213	-64,584	-98,847	-28,240	-4,540	-15,053	-18,704	-38,323	10,853	1,587	4,137	-8,936	21,750	15,909	-38,089	-32,303
Share Based Compensation	28.8%	4,647	3,608	1,835	5,556	6,612	4,877	8,646	6,078	10,102	10,432	2,479	13,925	11,508	11,583	12,131	10,591	8,188	7,963	7,883	6,883	4,774
Cashflow From Investing	-330.8%	-70,999	30,767	34,320	-19,610	-27,819	30,868	73,190	99,049	25,016	-99,491	50,649	127,929	23,686	-4,359	-102,468	-293,822	-364	-1,313	-	-	-5.00
Cashflow From Financing	130.0%	83.00	-277	60.00	364	38.00	-156	244	-505	-196	-110	426	-5,193	-5,606	-13,292	-14,154	-25,855	-19,316	433,400	-4,425	-47.00	200,543

AMRN Income Statement

2023-12-31

Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands

12 Months Ended

Dec. 31, 2023

Dec. 31, 2022

Dec. 31, 2021

Total revenue, net

$ 306,911

$ 369,193

$ 583,187

Less: Cost of goods sold

102,142

108,631

121,327

Less: Cost of goods sold - restructuring inventory

39,228

18,078

Gross margin

165,541

242,484

461,860

Operating expenses:

Selling, general and administrative

199,938

304,416

408,334

Research and development

22,219

30,411

29,307

Restructuring

10,972

13,526

13,717

Total operating expenses

233,129

348,353

451,358

Operating (loss) income

(67,588)

(105,869)

10,502

Interest income

11,863

2,819

1,220

Interest expense

(8)

(15)

(129)

Other income (expense), net

2,063

(740)

(302)

(Loss) income from operations before taxes

(53,670)

(103,805)

11,291

Provision for income taxes

(5,442)

(1,998)

(3,562)

Net (loss) income

$ (59,112)

$ (105,803)

$ 7,729

(Loss) earnings per share:

Basic

^[1]

$ (0.15)

$ (0.26)

$ 0.02

Diluted

^[1]

$ (0.15)

$ (0.26)

$ 0.02

Weighted average shares outstanding:

Basic

407,655

401,155

395,992

Diluted

407,655

401,155

402,480

Product Revenue, Net

Total revenue, net

$ 285,299

$ 366,511

$ 580,320

Licensing and Royalty Revenue

Total revenue, net

$ 21,612

$ 2,682

$ 2,867

[1]	Excluding the licensing revenue change in estimate and Medicaid change in estimate, both discussed in Note 12 – Revenue Recognition, net loss per share basic and diluted for the year ended December 31, 2023 would have been $(0.21).

AMRN Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current Assets:
Cash and cash equivalents	$ 199,252	$ 217,666
Restricted cash	525	523
Short-term investments	121,407	91,695
Accounts receivable, net	133,563	130,990
Inventory	258,616	228,732
Prepaid and other current assets	11,618	19,492
Total current assets	724,981	689,098
Property, plant and equipment, net	114	874
Long-term investments		1,275
Long-term inventory	77,615	163,620
Operating lease right-of-use asset	8,310	9,074
Other long-term assets	1,360	458
Intangible asset, net	19,304	21,780
TOTAL ASSETS	831,684	886,179
Current Liabilities:
Accounts payable	52,762	64,602
Accrued expenses and other current liabilities	204,174	192,678
Current deferred revenue	2,341	2,199
Total current liabilities	259,277	259,479
Long-Term Liabilities:
Long-term deferred revenue	2,509	13,147
Long-term operating lease liability	8,737	10,015
Other long-term liabilities	9,064	8,205
Total liabilities	279,587	290,846
Commitments and contingencies (Note 7)
Stockholders’ Equity:
Common stock, GBP 0.50 par, unlimited authorized; 418,141,295 shares issued, 408,824,093 shares outstanding at December 31, 2023; 412,333,087 shares issued, 404,346,256 shares outstanding at December 31, 2022	302,756	299,002
Additional paid-in capital	1,899,456	1,885,352
Treasury stock; 9,317,202 shares at December 31, 2023; 7,986,831 shares at December 31, 2022	(63,752)	(61,770)
Accumulated deficit	(1,586,363)	(1,527,251)
Total stockholders’ equity	552,097	595,333
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY	$ 831,684	$ 886,179

About Amarin Corp PLC

Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally to wholesalers and specialty pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

CEO	Mr. Patrick Holt
WEBSITE	amarincorp.com
INDUSTRY	Pharmaceuticals
EMPLOYEES	365

Amarin Corp PLC Frequently Asked Questions

What is the ticker symbol for Amarin Corp PLC? What does AMRN stand for in stocks?

AMRN is the stock ticker symbol of Amarin Corp PLC. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Amarin Corp PLC (AMRN)?

As of Fri Apr 26 2024, market cap of Amarin Corp PLC is 355.68 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of AMRN stock?

You can check AMRN's fair value in chart for subscribers.

What is the fair value of AMRN stock?

You can check AMRN's fair value in chart for subscribers. The fair value of Amarin Corp PLC is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Amarin Corp PLC is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for AMRN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Amarin Corp PLC a good stock to buy?

The fair value guage provides a quick view whether AMRN is over valued or under valued. Whether Amarin Corp PLC is cheap or expensive depends on the assumptions which impact Amarin Corp PLC's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for AMRN.

What is Amarin Corp PLC's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 26 2024, AMRN's PE ratio (Price to Earnings) is -6.02 and Price to Sales (PS) ratio is 1.16. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. AMRN PE ratio will change depending on the future growth rate expectations of investors.